Edition:
United Kingdom

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

173.42USD
22 Jun 2018
Change (% chg)

$0.93 (+0.54%)
Prev Close
$172.49
Open
$173.83
Day's High
$174.42
Day's Low
$172.26
Volume
715,263
Avg. Vol
756,010
52-wk High
$256.78
52-wk Low
$142.83

Latest Key Developments (Source: Significant Developments)

Allergan's Restasis Multidose 0.05% Approved In Canada
Thursday, 7 Jun 2018 

June 7 (Reuters) - Allergan plc ::ALLERGAN'S RESTASIS MULTIDOSE™ (CYCLOSPORINE OPHTHALMIC EMULSION) 0.05% APPROVED IN CANADA.ALLERGAN - RECEIVED APPROVAL FROM HEALTH CANADA FOR RESTASIS MULTIDOSE 0.05%.  Full Article

Appaloosa And Senator Investment Group Send Letter To Allergan’s Board
Tuesday, 5 Jun 2018 

June 5 (Reuters) - APPALOOSA::APPALOOSA AND SENATOR INVESTMENT GROUP SEND LETTER TO ALLERGAN’S BOARD OF DIRECTORS.APPALOOSA - WITH SENATOR INVESTMENT GROUP, REITERATE SUGGESTION THAT AT MINIMUM ALLERGAN SPLIT OFFICE OF CEO & CHAIRMAN.APPALOOSA SAYS ALSO REITERATE SUGGESTION THAT AT A MINIMUM, ALLERGAN RETAIN A NEW CHAIRMAN OR CEO FROM OUTSIDE COMPANY.APPALOOSA LP SAYS ALSO REITERATE SUGGESTION THAT AT A MINIMUM, ALLERGAN REPLACE AT LEAST TWO ADDITIONAL DIRECTORS ON CURRENT BOARD.APPALOOSA SAYS PREVIOUSLY, APPALOOSA AND SENATOR INVESTMENT GROUP SENT LETTERS TO ALLERGAN'S BOARD ON MAY 7, 2018 AND APRIL 23, 2018.  Full Article

Allergan Issues Nationwide Voluntary Recall Of Taytulla Softgel Capsules 1Mg/20Mcg Sample Packs Due To Out Of Sequence Capsules
Tuesday, 29 May 2018 

May 29 (Reuters) - Allergan plc ::ALLERGAN ISSUES NATIONWIDE VOLUNTARY RECALL OF TAYTULLA® SOFTGEL CAPSULES 1MG/20MCG SAMPLE PACKS DUE TO OUT OF SEQUENCE CAPSULES.ALLERGAN PLC - RECENTLY IDENTIFIED, THROUGH A PHYSICIAN REPORT, THAT FOUR PLACEBO CAPSULES WERE PLACED OUT OF ORDER IN A SAMPLE PACK OF TAYTULLA.ALLERGAN PLC - SPECIFICALLY, FIRST FOUR DAYS OF THERAPY HAD FOUR NON-HORMONAL PLACEBO CAPSULES INSTEAD OF ACTIVE CAPSULES.ALLERGAN - AS A RESULT OF PACKAGING ERROR, ORAL CONTRACEPTIVE CAPSULES MAY PLACE USER AT RISK FOR CONTRACEPTIVE FAILURE AND UNINTENDED PREGNANCY.ALLERGAN - VOLUNTARY RECALL IN U.S. MARKET OF ONE LOT (LOT# 5620706, EXPIRY MAY-2019) OF TAYTULLA.ALLERGAN PLC - RECALL IS BEING CONDUCTED WITH KNOWLEDGE OF US FOOD AND DRUG ADMINISTRATION.  Full Article

Axovant Says Gavin Corcoran, Chief Medical Officer Of Allergan, To Join Co As EVP Of R&D
Tuesday, 29 May 2018 

May 29 (Reuters) - Axovant Sciences Ltd ::AXOVANT STRENGTHENS MANAGEMENT TEAM AND COMPLETES ORGANIZATIONAL RESTRUCTURING IN PREPARATION FOR PIPELINE EXPANSION.AXOVANT SCIENCES LTD - AS PART OF RESTRUCTURING PLAN, INTERNAL HEADCOUNT HAS DECREASED BY APPROXIMATELY 43%.AXOVANT SCIENCES LTD - GAVIN CORCORAN, CURRENT CHIEF MEDICAL OFFICER OF ALLERGAN PLC, TO JOIN AXOVANT AS EVP OF RESEARCH AND DEVELOPMENT.  Full Article

Allergan Exercises Option To Acquire Compound From Aptinyx Discovery Platform
Tuesday, 22 May 2018 

May 22 (Reuters) - Allergan plc ::ALLERGAN EXERCISES OPTION TO ACQUIRE COMPOUND FROM APTINYX DISCOVERY PLATFORM UNDER ONGOING RESEARCH COLLABORATION.APTINYX - ALLERGAN EXERCISED OPTION TO ACQUIRE DRUG CANDIDATE AGN-241751, AN ORAL SMALL-MOLECULE N-METHYL-D-ASPARTATE.  Full Article

Carlyle Group Announces Launch Of Millicent Pharma With Acquisition Of Femring
Monday, 21 May 2018 

May 21 (Reuters) - Carlyle Group LP ::CARLYLE GROUP - LAUNCH OF MILLICENT PHARMA WITH ACQUISITION OF FEMRING.CARLYLE - CO, JOHN KING, ROGER BOISSONNEAULT, GEOFFREY ELLIOTT JOINTLY LAUNCH MILLICENT PHARMA; FEMRING ACQUIRED FROM ALLERGAN BY MILLICENT.CARLYLE GROUP - KING WILL SERVE AS CHAIRMAN OF MILLICENT PHARMA, BOISSONNEAULT AS CEO, AND GEOFFREY ELLIOTT AS CFO.CARLYLE GROUP - SEVERAL FORMER WARNER CHILCOTT SENIOR EXECUTIVES ALSO JOINING MILLICENT PHARMA LEADERSHIP TEAM.  Full Article

John Davidson Elected To Allergan Board Of Directors
Thursday, 3 May 2018 

Allergan plc ::JOHN DAVIDSON ELECTED TO ALLERGAN BOARD OF DIRECTORS.ALLERGAN PLC - ALLERGAN BOARD NOW HAS 12 MEMBERS.  Full Article

Myokardia Announces Appointment Of Taylor C. Harris As Chief Financial Officer
Wednesday, 4 Apr 2018 

April 4 (Reuters) - Myokardia Inc ::MYOKARDIA ANNOUNCES APPOINTMENT OF TAYLOR C. HARRIS AS CHIEF FINANCIAL OFFICER.HARRIS MOST RECENTLY SERVED AS CFO OF ZELTIQ AESTHETICS UNTIL THAT COMPANY'S ACQUISITION BY ALLERGAN PLC.JAKE BAUER ‍HAS BEEN PROMOTED TO ROLE OF CHIEF BUSINESS OFFICER ​.  Full Article

Allergan PLC CEO Brenton L. Saunders' 2017 Total Compensation Was $32.8 Million – SEC Filing‍​
Tuesday, 13 Mar 2018 

March 13 (Reuters) - Allergan Plc ::ALLERGAN PLC CEO BRENTON L. SAUNDERS' 2017 TOTAL COMPENSATION WAS $32.8 MILLION – SEC FILING‍​.ALLERGAN SAYS CFO MARIA TERESA HILADO FY 2017 TOTAL COMPENSATION WAS $10.8 MILLION ‍​.  Full Article

European Commission Approves Amgen, Allergan's Mvasi
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Amgen Inc ::EUROPEAN COMMISSION APPROVES AMGEN AND ALLERGAN'S MVASI® (BIOSIMILAR BEVACIZUMAB) FOR THE TREATMENT OF CERTAIN TYPES OF CANCER.AMGEN INC - EUROPEAN COMMISSION HAS GRANTED MARKETING AUTHORIZATION FOR MVASI.  Full Article

INTERVIEW-Israel's UroGen to start mid-stage bladder cancer trial

RAANANA, Israel, June 21 Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.